Biotech · Private company
Concert Pharmaceuticals
Track this companyFree. Adds Concert Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials210 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- CTP-543Phase 3 · Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- CTP-499Phase 2 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- CTP-692Phase 2 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-CTP-543Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Combined oral contraceptive containing Ethinyl estradiol (EE) and Levonorgestrel (LNG)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 1 · Health VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CTP-543Phase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- CTP-692Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- FluconazolePhase 1 · Health VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Health VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MoxifloxacinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials21
- Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy SubjectsPHASE1 · COMPLETED · started Jul 11, 2022ClinicalTrials.gov NCT05478772 · fetched Nov 12, 2026
- Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy SubjectsPHASE1 · COMPLETED · started Jun 21, 2022ClinicalTrials.gov NCT05467709 · fetched Nov 12, 2026
- Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy VolunteersPHASE1 · COMPLETED · started Jun 14, 2022ClinicalTrials.gov NCT05467696 · fetched Nov 12, 2026
- Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543PHASE1 · COMPLETED · started Jun 6, 2022ClinicalTrials.gov NCT05468749 · fetched Nov 12, 2026
- Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543PHASE1 · COMPLETED · started Jun 1, 2022ClinicalTrials.gov NCT05467722 · fetched Nov 12, 2026
- A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health VolunteersPHASE1 · COMPLETED · started Jan 4, 2022ClinicalTrials.gov NCT05192369 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)PHASE3 · COMPLETED · started Jun 10, 2021ClinicalTrials.gov NCT04797650 · fetched Nov 12, 2026
- Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult SubjectsPHASE1 · COMPLETED · started May 19, 2021ClinicalTrials.gov NCT04843540 · fetched Nov 12, 2026
- Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult SubjectsPHASE1 · COMPLETED · started Mar 2, 2021ClinicalTrials.gov NCT04743414 · fetched Nov 12, 2026
- A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia AreataPHASE2 · COMPLETED · started Feb 26, 2021ClinicalTrials.gov NCT04784533 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)PHASE3 · COMPLETED · started Nov 23, 2020ClinicalTrials.gov NCT04518995 · fetched Nov 12, 2026
- Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female SubjectsPHASE1 · COMPLETED · started Jun 9, 2020ClinicalTrials.gov NCT04309643 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaPHASE2 · COMPLETED · started Nov 26, 2019ClinicalTrials.gov NCT04158687 · fetched Nov 12, 2026
- Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male VolunteersPHASE1 · COMPLETED · started Sep 5, 2019ClinicalTrials.gov NCT04092712 · fetched Nov 12, 2026
- Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia AreataPHASE2 · COMPLETED · started May 24, 2019ClinicalTrials.gov NCT03941548 · fetched Nov 12, 2026
- Multiple Ascending Dose Study of CTP-692 in Healthy VolunteersPHASE1 · COMPLETED · started Apr 10, 2019ClinicalTrials.gov NCT03880253 · fetched Nov 12, 2026
- Food Effect Study of CTP-543 in Healthy VolunteersPHASE1 · COMPLETED · started Mar 25, 2019ClinicalTrials.gov NCT03880136 · fetched Nov 12, 2026
- Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia AreataPHASE2 · COMPLETED · started Mar 21, 2019ClinicalTrials.gov NCT03811912 · fetched Nov 12, 2026
- Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy VolunteersPHASE1 · COMPLETED · started Jan 24, 2019ClinicalTrials.gov NCT03830463 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia AreataPHASE2 · COMPLETED · started Aug 9, 2017ClinicalTrials.gov NCT03137381 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsPHASE2 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01487109 · fetched Nov 12, 2026